These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2562839)

  • 21. Molecular determinants of receptor affinity and selectivity of the natural delta-opioid agonist, dermenkephalin.
    Sagan S; Amiche M; Delfour A; Mor A; Camus A; Nicolas P
    J Biol Chem; 1989 Oct; 264(29):17100-6. PubMed ID: 2551895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity.
    Schiller PW; Nguyen TM; Chung NN; Lemieux C
    J Med Chem; 1989 Mar; 32(3):698-703. PubMed ID: 2537427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S; Sagan S; Delfour A; Nicolas P
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural requirements for dermorphin opioid receptor binding.
    Amiche M; Delfour A; Nicolas P
    Int J Pept Protein Res; 1988 Jul; 32(1):28-34. PubMed ID: 2906053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
    Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of peripheral opioid receptor subtypes in the modulation of gastric acid secretion and plasma gastrin in dogs.
    Intorre L; Mengozzi G; Vanni E; Grassi F; Soldani G
    Eur J Pharmacol; 1993 Oct; 243(3):265-72. PubMed ID: 8276079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6.
    Biondi L; Giannini E; Filira F; Gobbo M; Marastoni M; Negri L; Scolaro B; Tomatisc R; Rocchi R
    J Pept Sci; 2003 Oct; 9(10):638-48. PubMed ID: 14620129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity.
    Labroo VM; Hebel D; Kirk KL; Cohen LA; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1991 May; 37(5):430-9. PubMed ID: 1680830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding characteristics of dermorphin, and [dermorphin1-7]-beta c-endorphin in rat brain membranes.
    Westphal M; Hammonds RG; Li CH
    Peptides; 1985; 6(1):149-52. PubMed ID: 2986079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.
    Salvadori S; Guerrini R; Borea PA; Tomatis R
    Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, binding affinities and metabolic stability of dimeric dermorphin analogs modified with β3-homo-amino acids.
    Frączak O; Lasota A; Tymecka D; Kosson P; Muchowska A; Misicka A; Olma A
    J Pept Sci; 2016 Apr; 22(4):222-7. PubMed ID: 27028206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid receptor selectivity reversal in deltorphin tetrapeptide analogues.
    Lazarus LH; Salvadori S; Tomatis R; Wilson WE
    Biochem Biophys Res Commun; 1991 Jul; 178(1):110-5. PubMed ID: 1648906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides.
    Tomatis R; Marastoni M; Balboni G; Guerrini R; Capasso A; Sorrentino L; Santagada V; Caliendo G; Lazarus LH; Salvadori S
    J Med Chem; 1997 Aug; 40(18):2948-52. PubMed ID: 9288177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
    Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of β-azido(or 1-piperidinyl)methylamino acids in position 2 or 3 on biological activity and conformation of dermorphin analogues.
    Maciejczyk M; Lasota A; Frączak O; Kosson P; Misicka A; Nowakowski M; Ejchart A; Olma A
    J Pept Sci; 2016 Aug; 22(8):545-51. PubMed ID: 27443980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides.
    Gacel G; Zajac JM; Delay-Goyet P; Daugé V; Roques BP
    J Med Chem; 1988 Feb; 31(2):374-83. PubMed ID: 2828622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
    J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid receptors in the accessory optic system of the rat: effects of monocular enucleation.
    Giolli RA; Blanks RH; Torigoe Y; Clarke RJ; Fallon JH; Leslie FM
    Vis Neurosci; 1990 Nov; 5(5):497-506. PubMed ID: 1963079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.